ESMO25 Breast Cancer Highlights
2025 ESMO Prostate Cancer Highlights
2025 ESMO Kidney Cancer Highlights
2025 ESMO Bladder Cancer Highlights
New Phase 3 Clinical Trial Opens for Pediatric, Adult Hodgkin Lymphoma Patients
FLAURA2 Lung Cancer Study Presented by Pasi Jänne, MD, PhD
The Evolution of Cancer Predisposition Guidelines for Children
Updates in Breast Cancer Surgery
Physiatric Approach to Pain in Breast Cancer
Low-Dose Radiation Therapy for Arthritis
Modern Management of Borderline Resectable Pancreatic Cancer
Treatment Guideline: Inavolisib, Palbociclib, and Fulvestrant for Hormone Receptor-Positive/HER2-negative Metastatic Breast Cancer
Treatment Guideline: Ovarian Function Suppression and Estradiol Monitoring in Early-Stage Estrogen Receptor-Positive Breast Cancer
Tip Sheet: Adrenal Insufficiency in Breast Cancer Patients
AACR Pediatric Special Conference in Cancer Research
Is Subcutaneous Immunotherapy Ready for Prime Time? Join the June 23 webinar
Join Roswell Park Expert at 2nd Annual Upstate Cancer Symposium June 21
Dana-Farber researchers to present findings at 2025 San Antonio Breast Cancer Symposium
Dana-Farber Cancer Institute Faculty Among World's Most Highly Cited Researchers
Dana-Farber Research Points to Potential Gene Therapy Improvements
Three Ways Research Could Improve Pancreatic Cancer Treatment
FDA Approves Menin Inhibitor for Patients With Acute Leukemia With NPM1 Mutation, Backed by Dana-Farber Science
Pan-Mass Challenge Raises Record $78 Million for Dana-Farber Cancer Institute
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account
